top of page

Search Results

Results found for "Evaxion Biotech"

Posts (117)

  • Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer

    (“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today Vraniak served as Chief Financial Officer of Evaxion Biotech A/S, an AI enabled immuno-oncology company

  • How to Avoid the Most Common Gaps in Your Biotech Pitch

    Most biotech pitches don’t fail because the science is weak. A clear biotech pitch answers three key questions immediately. Strong biotech pitches don’t just inform, they align. How to Fix the Gaps 👉 Fixing your biotech pitch doesn’t require a rebrand. A strong biotech pitch isn’t about saying more.

  • The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway

    Every biotech founder fears the day the cash runs out. You track the burn rate. Most biotech founders don’t suffer from having the wrong people. Here’s the truth biotech founders miss. Alignment is not a culture topic. A soft skill. ✅ But in biotech, alignment is a multiplier. It’s how biotech companies move from drift to direction.

View All

Other Pages (98)

View All
bottom of page